Mirae Asset Global Investments Co. Ltd. Grows Position in GE HealthCare Technologies Inc. $GEHC

Mirae Asset Global Investments Co. Ltd. grew its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 11.6% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 178,382 shares of the company’s stock after acquiring an additional 18,500 shares during the period. Mirae Asset Global Investments Co. Ltd.’s holdings in GE HealthCare Technologies were worth $13,396,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also modified their holdings of the company. Allianz SE raised its holdings in GE HealthCare Technologies by 165.2% during the second quarter. Allianz SE now owns 350 shares of the company’s stock worth $26,000 after purchasing an additional 218 shares during the last quarter. E Fund Management Hong Kong Co. Ltd. increased its position in shares of GE HealthCare Technologies by 130.7% in the third quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock valued at $26,000 after buying an additional 196 shares in the last quarter. Godsey & Gibb Inc. acquired a new position in shares of GE HealthCare Technologies during the 3rd quarter worth $26,000. Gladwyn Financial Advisors Inc. acquired a new position in shares of GE HealthCare Technologies during the 2nd quarter worth $34,000. Finally, Piscataqua Savings Bank boosted its position in shares of GE HealthCare Technologies by 173.4% in the 3rd quarter. Piscataqua Savings Bank now owns 473 shares of the company’s stock worth $36,000 after buying an additional 300 shares in the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Performance

Shares of GEHC opened at $78.97 on Friday. The company has a market capitalization of $35.97 billion, a price-to-earnings ratio of 16.32, a PEG ratio of 2.38 and a beta of 1.08. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.95 and a current ratio of 1.18. GE HealthCare Technologies Inc. has a 1 year low of $57.65 and a 1 year high of $94.80. The company’s 50 day simple moving average is $82.63 and its 200 day simple moving average is $77.35.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share for the quarter, topping analysts’ consensus estimates of $1.05 by $0.02. The company had revenue of $5.14 billion for the quarter, compared to analyst estimates of $5.07 billion. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.The business’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.14 EPS. On average, sell-side analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Friday, January 9th will be given a dividend of $0.035 per share. The ex-dividend date is Friday, January 9th. This represents a $0.14 annualized dividend and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is 2.89%.

Analysts Set New Price Targets

Several equities analysts have weighed in on GEHC shares. Stifel Nicolaus raised their target price on shares of GE HealthCare Technologies from $90.00 to $95.00 and gave the company a “buy” rating in a report on Wednesday, January 7th. UBS Group lowered shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and increased their price target for the company from $73.00 to $77.00 in a research report on Thursday, January 15th. Jefferies Financial Group lifted their price objective on GE HealthCare Technologies from $95.00 to $105.00 and gave the stock a “buy” rating in a research report on Thursday, December 11th. Wells Fargo & Company reduced their target price on GE HealthCare Technologies from $89.00 to $87.00 and set an “overweight” rating on the stock in a research note on Thursday, October 30th. Finally, Piper Sandler increased their target price on GE HealthCare Technologies from $91.00 to $94.00 and gave the company an “overweight” rating in a report on Friday. Seven investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $90.33.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.